Role of savolitinib in advanced gastric adenocarcinoma with meningeal carcinomatosis and cerebellar metastasis: A case report

Table 1 Summary of previously published series of cases

Ref.	Case No.	Age/sex	BM	Therapy	Target point	Ending	Survival (month)
Cinar et al[19]	1	55/M	+	Gamma-knife; Irinotecan + trastuzumab	HER2	Dead	1
Cinar et al[19]	2	60/M	+	Radiotherapy; Trastuzumab + capecitabine + carboplatin; Clinical trial	HER2	Dead	24
Katayanagi et al[20]	3	77/M	+	X-knife + surgical resection	Unknown	PR	> 12
Kitayama et al[21]	4	76/M	+	Paclitaxel + surgical resection + radiation therapy	Unknown	PR	5
Sakurai et al[22]	5	78/F	+	Radiation therapy	Unknown	Dead	4
Rino et al[23]	6	63/M	+	Irinotecan + cisplatin + radiation therapy	Unknown	PR	No specified
Rino et al[23]	7	78/M	+	Irinotecan + cisplatin + Cyber-knife	Unknown	PR	No specified
Kostoglou et al[24]	8	69/F	+	Radiation therapy + surgical resection	HER2	Dead	4
Ahn et al[25]	9	38/M	+	Stereotactic radiosurgery + anti-PD-1	Unknown	PR	> 26
Kosco et al[26]	10	73/F	+	Radiation therapy + surgical resection + pharmacological intervention	Unknown	CR	> 26
Murakami et al[27]	11	65/M	+	Supportive care	Unknown	Dead	1

BM: Brain metastases; PR: Partial response; CR: Complete response; HER2: Human epidermal growth factor receptor 2.